Therapeutic Advances in Psychopharmacology

SJR Rank #3,070H-index: 52SJR: 1.321Best quartile: Q1Open AccessAPC: US$2,650Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Inc.

Country

United Kingdom

Type

journal

SJR by Edition

Only one SJR edition is available for this journal so far.

Subject Categories

  • Pharmacology (medical)Q1
  • Psychiatry and Mental HealthQ1

Areas: Medicine

Most published research topics

Schizophrenia research and treatmentTreatment of Major DepressionBipolar Disorder and TreatmentTryptophan and brain disordersElectroconvulsive Therapy StudiesHealthcare Decision-Making and RestraintsNeurotransmitter Receptor Influence on BehaviorPsychedelics and Drug StudiesMental Health and PsychiatryForensic Toxicology and Drug Analysis

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0306090120

Documents per Year

Only one SJR edition is available for this journal so far.

Detailed Information

ISSN

2045-1261, 2045-1253

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.39

References per Document

54.06

Coverage

2011-2026

Scope

No scope description available yet.

Metrics from SCImago Journal Rank 2025. View on SCImago